KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsBuildingsCash & EquivalentsCommon EquityConstruction in ProgressCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLand & ImprovementsLiabilities and Shareholders EquityLoans - NetLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesReal Estate - NetReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Healthpeak Properties (DOC) Goodwill & Intangibles (2016 - 2025)

Healthpeak Properties (DOC) has disclosed Goodwill & Intangibles for 17 consecutive years, with $68.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill & Intangibles fell 92.89% to $68.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $68.5 million, a 92.89% decrease, with the full-year FY2024 number at $885.8 million, up 166.68% from a year prior.
  • Goodwill & Intangibles was $68.5 million for Q3 2025 at Healthpeak Properties, roughly flat from $68.5 million in the prior quarter.
  • In the past five years, Goodwill & Intangibles ranged from a high of $963.5 million in Q3 2024 to a low of $29.0 million in Q1 2021.
  • A 5-year average of $416.7 million and a median of $436.1 million in 2022 define the central range for Goodwill & Intangibles.
  • Peak YoY movement for Goodwill & Intangibles: soared 1692.28% in 2021, then tumbled 92.89% in 2025.
  • Healthpeak Properties' Goodwill & Intangibles stood at $519.8 million in 2021, then dropped by 16.1% to $436.1 million in 2022, then fell by 23.83% to $332.2 million in 2023, then skyrocketed by 166.68% to $885.8 million in 2024, then tumbled by 92.26% to $68.5 million in 2025.
  • Per Business Quant, the three most recent readings for DOC's Goodwill & Intangibles are $68.5 million (Q3 2025), $68.5 million (Q1 2025), and $885.8 million (Q4 2024).